The planned program also includes volixibat analyses of itching, fatigue and sleep, plus LIVMARLI outcomes; the meeting runs Nov. 5-9 in Denver.
Organizations using Microsoft Fabric data agents should re-verify their response quality this week. Between November 2 and ...
FDA sets PDUFA target action date of May 1, 2027 ~~ If approved, ifezuntirgene inilparvovec will be the world’s first disease-modifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results